+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AAREYDRUGS

Aarey Drugs & Pharmaceuticals Share Price

₹116.03 +3.83 (3.41%)
New 52W High today

20 Nov, 2026 3:54 PM (IST)

Aarey Drugs & Pharmaceuticals live price: ₹116.03. It opened at ₹115 vs previous close ₹112; intraday high/low: ₹117/₹113. The 50 & 200 DMA stand at ₹105.00/₹89.60.

Aarey Drugs & Pharmaceuticals Performance

  • Today's Low
  • ₹113
  • Today's High
  • ₹117
  • 52 Week Low
  • ₹50
  • 52 Week High
  • ₹117
  • Open Price₹115
  • Previous Close₹112
  • Volume268,295
  • 50 DMA₹105.00
  • 100 DMA₹98.00
  • 200 DMA₹89.60

Aarey Drugs & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 1.9%
  • Over 3 Month + 43.98%
  • Over 6 Month + 36.41%
  • Over 1 Year + 22.69%

Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 72.8
  • PEG Ratio
  • 2.8
  • Market Cap Cr
  • 329
  • P/B Ratio
  • 2.2
  • Average True Range
  • 5.2
  • EPS
  • 1.6
  • Dividend Yield
  • 0
  • MACD Signal
  • 2
  • RSI
  • 61.35
  • MFI
  • 55.66

Latest Stock News Updates

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the company has published and extract of statement of unaudited standalone Financial Results for the Second quarter and Half Year ended on September 30, 2026, which have been considered, approved and taken on record by the Board of Directors, at their meeting held on Saturday, 14th November, 2026. The said financial results have been published in 'Active Times' (English Newspaper) edition dated 17/11/2026 & in 'Mumbai lakshadeep' (Marathi newspaper) edition dated 16/11/2026.

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Statement Of Deviation And Variation For The Quarter Ended September 30, 2026

Statement of deviation and variation for the quarter ended September 30, 2026

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Unaudited Financial Results For The Second Quarter & Half Year Ended On 30Th September, 2026

As per attachment

Aarey Drugs & Pharmaceuticals Financials

Aarey Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹116.03
+ 3.83 (3.41%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹109.90
  • 50 Day
  • ₹105.00
  • 100 Day
  • ₹98.00
  • 200 Day
  • ₹89.60

Resistance and Support

115.34 Pivot Speed
  • R3 121.40
  • R2 119.10
  • R1 117.60
  • S1 113.80
  • S2 111.60
  • S3 110.00

Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-14 Quarterly Results
2026-08-14 Quarterly Results
2026-05-30 Audited Results (Revised)
2026-02-11 Quarterly Results
2025-11-13 Quarterly Results
Date Purpose Remarks
2017-10-13 Split

Aarey Drugs & Pharmaceuticals Shareholding Pattern

52.83%
41.45%
4.28%
1.44%

About Aarey Drugs & Pharmaceuticals

Nature of Business Activity: Manufacturing &Trading in Chemical Products, Solvent, and Drugs Intermediates etc. View More
  • NSE Symbol
  • AAREYDRUGS
  • BSE Symbol
  • 524412
  • ISIN
  • INE198H01019

Similar Stocks to Aarey Drugs & Pharmaceuticals

Aarey Drugs & Pharmaceuticals FAQs

Aarey Drugs & Pharmaceuticals share price is ₹116 As on 21 November, 2026 | 18:07

The Market Cap of Aarey Drugs & Pharmaceuticals is ₹329 Cr As on 21 November, 2026 | 18:07

The P/E ratio of Aarey Drugs & Pharmaceuticals is 72.8 As on 21 November, 2026 | 18:07

The PB ratio of Aarey Drugs & Pharmaceuticals is 2.2 As on 21 November, 2026 | 18:07

The 52 week High & Low of Aarey Drugs & Pharmaceuticals is ₹116.9/₹50.3 respectively As on 21 November, 2026 | 18:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23